Crossmark

Guide from the Colegio Mexicano de Reumatología for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial Hypertension

Crossref DOI link: https://doi.org/10.1016/j.reumae.2026.502164

Published Print: 2026-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Chacón-Abril, Karla

Portela-Hernández, Margarita

Fajardo-Hermosillo, Luis Daniel

Limón-Camacho, Leonardo

Ruiz-Gómez, Natllely Itzel

Pacheco-Tena, César

Barrera-Rodríguez, Aarón Alejandro

Vera-Lastra, Olga

Mejía, Mayra

Buedía-Roldán, Ivette

Martínez-Espinosa, Karen

Mateos, Heidegger

Méndez Flores, Silvia

Pulido-Zamudio, Tomás

Zayas-Hernández, Nayeli

García-Cuellar, José Antonio

Navarro-Vergara, Dulce

Rojas-Serrano, Jorge

Medrano-Ramírez, Gabriel

Rodríguez-Reyna, Tatiana S.
License Information

Text and Data Mining valid from 2026-05-01

Text and Data Mining valid from 2026-05-01
More Information

This article is maintained by: Elsevier

Article Title: Guide from the Colegio Mexicano de Reumatología for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial Hypertension

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2026.502164

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2026.502164

Content Type: simple-article

Copyright: © 2026 Sociedad Española de Reumatología (SER), Colegio Mexicano de Reumatología (CMR) and Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Document is current

Any future updates will be listed below